Suppr超能文献

中性粒细胞与淋巴细胞比值在宫颈癌中的预后意义:一项观察性研究的系统评价和荟萃分析

Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies.

作者信息

Huang Qi-Tao, Man Qian-Qian, Hu Jia, Yang Yi-Lin, Zhang Yue-Mei, Wang Wei, Zhong Mei, Yu Yan-Hong

机构信息

Division of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.

Southern Medical University, Guangzhou, 510515, China.

出版信息

Oncotarget. 2017 Mar 7;8(10):16755-16764. doi: 10.18632/oncotarget.15157.

Abstract

BACKGROUND AND AIMS

The prognostic role of neutrophil-to-lymphocyte ratio (NLR) in cervical cancer are controversial. We conducted this meta-analysis to obtain a more accurate assessment of prognostic significance of NLR in cervical cancer.

RESULTS

A total of 9 studies, consisting of 2,804 patients, were selected in this meta-analysis. Our pooled results showed that high pre-treatment NLR level was significantly associated with poorer overall survival (HR: 1.88, 95% CI 1.30-2.73) and shorter progression free survival (HR 1.65, 95% CI 1.18-2.29). Additionally, increased NLR was also significantly correlated with tumor size (OR 2.05, 95% CI 1.14-3.65), advanced FIGO stage (OR 2.12, 95% CI1.28-3.49) and lymph node involvement (OR 2.24, 95% CI 1.65-3.04).

MATERIALS AND METHODS

We conducted a systematic literature search using the electronic databases PubMed, Web of Science, and Embase up to May 2016.Statistical analysis was performed using Stata 10.0.

CONCLUSIONS

Elevated pretreatment NLR could serve as a predicative factor of poor prognosis for cervical cancer patients.

摘要

背景与目的

中性粒细胞与淋巴细胞比值(NLR)在宫颈癌中的预后作用存在争议。我们进行了这项荟萃分析,以更准确地评估NLR在宫颈癌中的预后意义。

结果

本荟萃分析共纳入9项研究,涉及2804例患者。我们的汇总结果显示,治疗前NLR水平较高与较差的总生存期(HR:1.88,95%CI 1.30 - 2.73)和较短的无进展生存期(HR 1.65,95%CI 1.18 - 2.29)显著相关。此外,NLR升高还与肿瘤大小(OR 2.05,95%CI 1.14 - 3.65)、国际妇产科联盟(FIGO)分期较晚(OR 2.12,95%CI 1.28 - 3.49)和淋巴结受累(OR 2.24,95%CI 1.65 - 3.04)显著相关。

材料与方法

我们使用电子数据库PubMed、Web of Science和Embase进行了系统的文献检索,检索截至2016年5月。使用Stata 10.0进行统计分析。

结论

治疗前NLR升高可作为宫颈癌患者预后不良的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/5369999/3e41e90508ca/oncotarget-08-16755-g001.jpg

相似文献

4
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
Gynecol Oncol. 2017 Jun;145(3):584-594. doi: 10.1016/j.ygyno.2017.02.026. Epub 2017 Feb 20.
5
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Modulation of Chronic Cytokine Dysregulation in Cervical Cancer: Potential Biomarkers and Therapeutic Targets.
Cancer Manag Res. 2025 Jun 13;17:1113-1126. doi: 10.2147/CMAR.S527913. eCollection 2025.
2
Neutrophil extracellular traps in diseases of the female reproductive organs.
Front Immunol. 2025 May 5;16:1589329. doi: 10.3389/fimmu.2025.1589329. eCollection 2025.
6
Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis.
Front Oncol. 2024 Dec 23;14:1461175. doi: 10.3389/fonc.2024.1461175. eCollection 2024.
8
Preoperative neutrophil/lymphocyte ratio as prognostic factor in epithelial ovarian cancer.
Rev Colomb Obstet Ginecol. 2024 Mar 20;75(1):4046. doi: 10.18597/rcog.4046.

本文引用的文献

6
Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
Semin Immunol. 2016 Apr;28(2):187-96. doi: 10.1016/j.smim.2016.03.018. Epub 2016 Apr 7.
8
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma.
Cancer Immunol Immunother. 2016 Jun;65(6):651-62. doi: 10.1007/s00262-016-1826-5. Epub 2016 Mar 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验